TLDR
- Rocket Lab (RKLB) jumped 10.2% on Tuesday, closing at $78.59, its third consecutive day of gains.
- The rally came as the company announced two upcoming Electron rocket launches within days of each other.
- Trading volume hit 28.4 million — roughly 33% above the daily average.
- Bank of America holds a price target of $120 on RKLB, well above the consensus target of $75.92.
- Insiders sold around $139 million worth of stock over the past three months, though institutions still own about 71.8% of the company.
Rocket Lab stock climbed 10.2% on Tuesday, closing at $78.59. The move came on the back of two upcoming Electron rocket launches announced by the company.
The stock had closed at $71.31 the day before, and Tuesday marked the third straight day of gains for RKLB.
Volume told its own story: 28.4 million units changed hands during the session — 33% above the average daily volume of around 21.3 million.
The company announced it would launch its 84th Electron mission, called “Eight Days A Week,” no later than Friday, March 20. That mission will carry a synthetic aperture radar satellite into low Earth orbit (LEO) for Synspective’s StriX constellation.
T-6 days to launch for "Daughter Of The Stars" – Electron's 85th launch and first time flying a dedicated mission for the European Space Agency @esa 🛰️🛰️.
Integration and encapsulation is now complete, with ESA's 2x satellites secured to Electron inside its nose cone and ready… pic.twitter.com/kFH27E1a0n
— Rocket Lab (@RocketLab) March 17, 2026
A second launch, the 85th Electron mission named “Daughter of the Stars,” is scheduled no later than Tuesday, March 24. That one marks Rocket Lab’s first mission for the European Space Agency (ESA), deploying two Pathfinder A satellites to test a new LEO satnav system.
“Integration and encapsulation is now complete, with ESA’s 2x satellites secured to Electron inside its nose cone and ready for launch,” Rocket Lab said in a post on X.
Both launches are set to lift off from Launch Complex 1 at Mahia Peninsula in New Zealand.
Analyst Targets and Ratings
Wall Street’s view on RKLB is broadly positive, though not unanimous. The current consensus rating sits at “Moderate Buy,” with an average price target of $75.92 — just below where the stock closed Tuesday.
Bank of America stands out as the most bullish voice, raising its price target from $60 to $120 in January and slapping a “Buy” rating on the stock.
The broader analyst breakdown includes one Strong Buy, seven Buys, seven Holds, and one Sell. Zacks moved the stock from Strong Buy to Hold back in February, while TD Cowen has maintained its Buy rating.
The company carries a market cap of $41.98 billion, a debt-to-equity ratio of just 0.10, a quick ratio of 3.61, and a current ratio of 4.08. Its 200-day moving average sits at $63.25.
Insider Activity
Not everyone is buying in at these levels. Over the last three months, insiders have sold roughly 1.85 million units worth approximately $139 million in total.
SVP Arjun Kampani sold 23,711 units on March 4 at an average price of $71.95, reducing his position by 5.62%. Insider Frank Klein also sold 36,768 units the same day at the same price, trimming his stake by 3.27%.
Despite the selling activity, corporate insiders still hold 11.9% of the company. Institutional investors and hedge funds own approximately 71.8%, with several smaller funds initiating new positions in the fourth quarter of last year.
RKLB carries a trailing P/E of -212.40 and a beta of 2.20, reflecting its high volatility profile. The 50-day moving average stands at $77.33.





